Analysis of adult 20-year survivors after liver transplantation
Open Access
- 18 September 2014
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 9 (3) , 461-470
Abstract
Background: Liver transplantation (LT) is the treatment of choice for chronic and acute liver failure; however, the status of long-term survivors and allograft function is not well known.Aim: To evaluate the clinical outcome and allograft function of survivors 20 years post-LT, cause of death during the same period and risk factors of mortality.Methods: A retrospective study was conducted from prospective, longitudinal data collected at a single center of adult LT recipients surviving 20 years. A comparative sub-analysis was made with patients who were not alive 20 years post-transplantation to identify the causes of death and risk factors of mortality.Results: Between 1988 and 1994, 132 patients received 151 deceased-donors LT and 28 (21 %) survived more than 20 years. Regarding liver function in this group, medians of AST, ALT and total bilirubin at 20 years post-LT were 33 IU/L (13–135 IU/L), 27 (11–152 IU/L) and 0.6 mg/dL (0.3–1.1 mg/dL). Renal dysfunction was observed in 40 % of patients and median eGFR among 20-year survivors was 64 mL/min/1.73 m2(6–144 mL/min/1.73 m2). Sixty-one percent of 20-year survivors had arterial hypertension, 43 % dyslipidemia, 25 % de novo tumors and 21 % diabetes mellitus. Infections were the main cause of death during the 1st year post-transplant (32 %) and between the 1st and 5th year post-transplant (25 %). After 5th year from transplant, hepatitis C recurrence (22 %) became the first cause of death. Factors having an impact on long-term patient survival were HCC indication (p = 0.049), pre-transplant renal dysfunction (p = 0.043) and long warm ischemia time (p = 0.016); furthermore, post-transplant factors were diabetes mellitus (p = 0.001) and liver dysfunction (p = 0.05) at 1 year.Conclusion: Our results showed the effect of immunosuppression used during decades on long-term outcome in our LT patients in terms of morbidity (arterial hypertension, diabetes mellitus, dyslipidemia and renal dysfunction) and mortality (infections and hepatitis C recurrence).Keywords
This publication has 46 references indexed in Scilit:
- Twenty-Year Longitudinal Follow-Up After Orthotopic Liver Transplantation: A Single-Center Experience of 313 Consecutive CasesAmerican Journal of Transplantation, 2013
- Biliary complications adversely affect patient and graft survival after liver retransplantationLiver Transplantation, 2013
- Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled TrialAmerican Journal of Transplantation, 2012
- Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centreHepatology International, 2010
- Long-Term Patient Outcome and Quality of Life After Liver TransplantationAnnals of Surgery, 2010
- De novo malignancies following liver transplantation: Impact and recommendationsLiver Transplantation, 2009
- Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and managementLiver International, 2009
- Patient Outcomes in Two Steroid-Free Regimens Using Tacrolimus Monotherapy After Daclizumab Induction and Tacrolimus With Mycophenolate Mofetil in Liver TransplantationTransplantation, 2008
- Long-term results after liver transplantationTransplant International, 2008
- National Institutes of Health Consensus Development Conference Statement: Liver2 Transplantation-June 20-23, 1983Hepatology, 1984